Financial reports
10-Q
2024 Q3
Quarterly report
12 Feb 24
10-Q
2024 Q2
Quarterly report
9 Nov 23
10-Q
2024 Q1
Quarterly report
10 Aug 23
10-K
2023 FY
Annual report
22 May 23
10-Q
2023 Q3
Quarterly report
3 Feb 23
10-Q
2023 Q2
Quarterly report
4 Nov 22
10-Q
2023 Q1
Quarterly report
5 Aug 22
10-K
2022 FY
Annual report
8 Jun 22
10-Q
2022 Q3
Quarterly report
4 Feb 22
10-Q
2021 Q2
Quarterly report
5 Nov 21
Current reports
8-K
Results of Operations and Financial Condition
12 Feb 24
8-K
Regulation FD Disclosure
9 Jan 24
8-K
Immunovant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
20 Dec 23
8-K
Immunovant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class Potential
28 Nov 23
8-K
Results of Operations and Financial Condition
9 Nov 23
8-K
Entry into a Material Definitive Agreement
28 Sep 23
8-K
Immunovant Announces Positive Initial IMVT-1402 Phase 1 SAD and 300 mg Subcutaneous MAD Results
26 Sep 23
8-K
Submission of Matters to a Vote of Security Holders
23 Aug 23
8-K
Results of Operations and Financial Condition
10 Aug 23
8-K
Results of Operations and Financial Condition
22 May 23
Registration and prospectus
S-8
Registration of securities for employees
15 Apr 24
S-3ASR
Automatic shelf registration
9 Nov 23
424B5
Prospectus supplement for primary offering
29 Sep 23
FWP
Free writing prospectus
28 Sep 23
FWP
Free writing prospectus
26 Sep 23
424B5
Prospectus supplement for primary offering
26 Sep 23
S-8
Registration of securities for employees
5 Apr 23
S-8
Registration of securities for employees
3 Feb 23
424B5
Prospectus supplement for primary offering
5 Oct 22
S-8
Registration of securities for employees
8 Jun 22
Proxies
DEFA14A
Additional proxy soliciting materials
26 Jun 23
DEF 14A
Definitive proxy
26 Jun 23
DEFA14A
Additional proxy soliciting materials
30 Jun 22
DEF 14A
Definitive proxy
30 Jun 22
DEF 14A
Definitive proxy
12 Aug 21
PRE 14A
Preliminary proxy
2 Aug 21
DEFA14A
Additional proxy soliciting materials
9 Jul 20
DEF 14A
Definitive proxy
9 Jul 20
DEFA14A
Additional proxy soliciting materials
13 Dec 19
DEFA14A
Additional proxy soliciting materials
2 Dec 19
Other
UPLOAD
Letter from SEC
18 Feb 21
CORRESP
Correspondence with SEC
17 Feb 21
UPLOAD
Letter from SEC
2 Feb 21
EFFECT
Notice of effectiveness
15 Jan 21
CORRESP
Correspondence with SEC
12 Jan 21
UPLOAD
Letter from SEC
11 Jan 21
EFFECT
Notice of effectiveness
2 Sep 20
CORRESP
Correspondence with SEC
31 Aug 20
CORRESP
Correspondence with SEC
31 Aug 20
UPLOAD
Letter from SEC
27 Aug 20